We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
Frequently asked questions
What sector does We&Win Diversification Co Ltd (4113) operate in?
We&Win Diversification Co Ltd belongs to the Industrials sector and operates in the Engineering & Construction industry.
What is We&Win Diversification Co Ltd (4113) current stock price?
As of the latest data, We&Win Diversification Co Ltd stock price is NT$14.90, with a previous close of NT$14.85. We&Win Diversification Co Ltd gained NT$0.05 in the last trading session, representing a 0.34% increase.
What is We&Win Diversification Co Ltd (4113) current market capitalization?
We&Win Diversification Co Ltd market cap is approximately 3.44 billion.
What is We&Win Diversification Co Ltd (4113) Earnings Per Share (EPS)?
The trailing EPS is -NT$0.71.
Does We&Win Diversification Co Ltd (4113) pay dividends?
Yes. We&Win Diversification Co Ltd pays annual dividends with an annualized yield of 5.7% and an estimated annual payout of NT$0.85 per share.
When is the next ex-dividend date for We&Win Diversification Co Ltd (4113)?
The next ex-dividend date is scheduled for August 28, 2026.
What is We&Win Diversification Co Ltd (4113) beta (volatility) score?
We&Win Diversification Co Ltd has a beta of -0.079, indicating lower volatility than the overall market.
